India Board Rules against Bayer in Patent Case
Moneylife Digital Team 22 March 2013

An Indian patent appeals board upheld the decision to allow Natco Pharma to sell a generic version of Bayer AG’s cancer drug, Nexavar. Bayer AG, Germany’s largest drug-maker, said it would...

Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
Get access to complete archives
Rs 5000 + GST
Already a subscriber ? Log in
Free Helpline
Legal Credit